Levofloxacin cures experimental pneumonic plague in African green monkeys.
BACKGROUND: Yersinia pestis, the agent of plague, is considered a potential bioweapon due to rapid lethality when delivered as an aerosol. Levofloxacin was tested for primary pneumonic plague treatment in a nonhuman primate model mimicking human disease. METHODS AND RESULTS: Twenty-four African Gree...
Saved in:
Main Authors: | Robert Colby Layton (Author), William Mega (Author), Jacob D McDonald (Author), Trevor L Brasel (Author), Edward B Barr (Author), Andrew P Gigliotti (Author), Frederick Koster (Author) |
---|---|
Format: | Book |
Published: |
Public Library of Science (PLoS),
2011-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
An encapsulated Yersinia pseudotuberculosis is a highly efficient vaccine against pneumonic plague.
by: Anne Derbise, et al.
Published: (2012) -
Complete Protection against Pneumonic and Bubonic Plague after a Single Oral Vaccination.
by: Anne Derbise, et al.
Published: (2015) -
Spray-Dried Inhalable Powder Formulations of Gentamicin Designed for Pneumonic Plague Therapy in a Mouse Model
by: Menghuan Zhu, et al.
Published: (2022) -
Aspiration Pneumonitis Caused by Polyethylene Glycol-Electrolyte Solution Treated with Conservative Management
by: Ricardo A. Mosquera, et al.
Published: (2014) -
Modeling mosquito-borne and sexual transmission of Zika virus in an enzootic host, the African green monkey.
by: Andrew D Haddow, et al.
Published: (2020)